An early roadmap to preventing a devastating childhood brain cancer
Stopping genetic mutations that cause a rare but aggressive brain tumor in children may be the key to preventing the cancer’s development in the first place, according to researchers in the UW School of Medicine and Public Health.
Cell therapy for Parkinson’s shows promise
Parkinson’s patients are receiving a new investigational treatment thanks to groundbreaking research by Dr. Marina Emborg, a professor of medical physics in the University of Wisconsin School of Medicine and Public Health.
Andrea Putnam awarded 2025 Packard Fellowship
Andrea A. Putnam, a University of Wisconsin School of Medicine and Public Health assistant professor of biomolecular chemistry, has been named a 2025 Packard Foundation Fellow in Science and Engineering.
Understanding the effects of social media on teens
Hundreds of Wisconsin teens are helping UW researchers understand more about their online life, with potentially transformative results.
UW–Madison to lead nation in boron neutron capture therapy for cancer
The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy (BNCT) center in the United States.
Researching voice disorders is top strength of new department
UW is known nationwide for its expertise in laryngology, the care of patients with voice, airway and swallowing disorders. The specialty is a key strength of the new Department of Otolaryngology-Head and Neck Surgery, which became the school’s 28th department in June after nine decades of growth and innovation as a division within the Department of Surgery.
Q&A: Jacques Galipeau on cell therapies to cure disease
Dr. Jacques Galipeau is the associate dean for therapeutics development and the director of the Program for Advanced Cell Therapy (PACT), a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health that aims to bring innovative cell therapies to patients. He is also a practicing hematologist, treating patients with blood clot disorders, anemia, and other diseases and conditions.
James Dahlberg receives American Innovator Award
James Dahlberg, a professor emeritus of biomolecular chemistry whose research led to a widely accessible colon cancer screening test, received the American Innovator Award from the Bayh-Dole coalition in June.
World Breast Cancer Research Day
World Breast Cancer Research Day is celebrated on the 18th day of the eighth month of the year — a reference to the one in eight women and one in 833 men who will be diagnosed with breast cancer in their lifetimes. The day is intended to amplify the urgency of preventing disease and finding cures, as well as shine a light on critical research, including studies supported by federal funding.
First impressions: a Q&A with Dean Ahuja
On May 15, 2025, Nita Ahuja, MD, MBA, became the 10th dean of the University of Wisconsin School of Medicine and Public Health and vice chancellor for medical affairs at UW–Madison.
Freeing kidney transplant patients from daily anti-rejection medications
Kidney transplant patients are embracing a new chapter of life, thanks to a groundbreaking clinical trial that eliminates the need for a lifelong regimen of anti-rejection drugs, which can cause serious side effects.
How cells rust to death with age
In the same way that sheet music shows musicians what to play, DNA shows the body how to function. But what if a violinist’s pages got jumbled out of order, or the melodies marked mute? The instructions would still be there, but they wouldn’t make sense to the player.